Tag: Versanis Bio

Browse exclusive Tags!

Eli Lilly Acquires Obesity Startup Versanis for Nearly $2 Billion

Eli Lilly acquires Versanis Bio for $2 billion, gaining access to obesity drug bimagrumab. Major move in the growing pharmaceutical obesity market.

Popular

Subscribe

spot_imgspot_img